Back to results
US 8,784,816 B2Granted
Antibodies which bind factor VIII
AssigneeLife Sciences Research Partners VZW
InventorsMarc G. Jacquemin, Jean-Marie R. Saint-Remy
Life of this patent
Estimating the term…
Abstract
The invention, in general, features a method of treatment and/or prevention of a thrombotic pathological condition, in a mammal, which includes administering to the mammal in need of such treatment a therapeutically effective amount of a composition including an antibody directed against the C1 domain of Factor VIII, which is a partially inhibitory antibody of Factor VIII.
Claims3
An isolated monoclonal antibody directed against factor VIII which is partially inhibiting factor VIII procoagulant activity, wherein said antibody is comprising:
- heavy chain variable region CDR1, CDR2 and CDR3 corresponding to SEQ ID NOs:
- 33, 34 and 35, respectively, and light chain variable region CDR1, CDR2 and CDR3 corresponding to SEQ ID NOs:
- 36, 37 and 38, respectively;
- or
- heavy chain variable region CDR1, CDR2 and CDR3 corresponding to SEQ ID NOs:
- 39, 40 and 41, respectively, and light chain variable region CDR1, CDR2 and CDR3 corresponding to SEQ ID NOs:
- 42, 43 and 44, respectively;
- or an antigen-binding fragment of any of said antibodies.
5 more elements
Dependencies are inferred from the claim text.